Trademark: 97453092
Word
GLYSTALI
Status
Pending
Status Code
730
Status Date
Tuesday, December 19, 2023
Serial Number
97453092
Mark Type
4000
Filing Date
Friday, June 10, 2022
Published for Opposition
Tuesday, May 30, 2023

Trademark Owner History
Zydus Pharmaceuticals (USA) Inc. - Owner At Publication

Classifications
5 Anti-inflammatories; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; Pharmaceutical preparations for the treatment and prevention of hematalogic disorders and for use in tissue and organ transplantation; Pharmaceutical preparations for the treatment and prevention of eye diseases and conditions; Pharmaceutical preparations for the treatment and prevention of heart rhythm disorders; Pharmaceutical preparations for the treatment and prevention of immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of kidney diseases; Pharmaceutical preparations for the treatment and prevention of hypertension; Pharmaceutical preparations for the treatment and prevention of skin disorders; Pharmaceutical preparations for the treatment and prevention of cancer and tumors; Pharmaceutical preparations for the treatment and prevention of allergies; Pharmaceutical preparations for the treatment and prevention of bone diseases; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and asthma; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use

Trademark Events
Dec 21, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 19, 2023
Sou Extension 1 Granted
Dec 19, 2023
Sou Extension 1 Filed
Dec 19, 2023
Sou Teas Extension Received
Dec 18, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Dec 18, 2023
Teas Change Of Correspondence Received
Dec 18, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 18, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 25, 2023
Noa E-Mailed - Sou Required From Applicant
May 30, 2023
Official Gazette Publication Confirmation E-Mailed
May 30, 2023
Published For Opposition
May 10, 2023
Notification Of Notice Of Publication E-Mailed
Apr 24, 2023
Approved For Pub - Principal Register
Apr 22, 2023
Teas/Email Correspondence Entered
Apr 21, 2023
Correspondence Received In Law Office
Apr 21, 2023
Teas Response To Office Action Received
Feb 21, 2023
Notification Of Non-Final Action E-Mailed
Feb 21, 2023
Non-Final Action E-Mailed
Feb 21, 2023
Non-Final Action Written
Feb 15, 2023
Assigned To Examiner
Jun 23, 2022
New Application Office Supplied Data Entered
Jun 14, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24